Ostarine (MK 2866) Powder For Bodybuilding CAS:841205-47-8

   Ostarine (MK-2866), a pioneering Selective Androgen Receptor Modulator (SARM), emerged from GTx, Inc.'s labs in the early 2000s as a therapy for muscle wasting. Unlike traditional anabolics, Ostarine's partial androgen receptor (AR) agonism allows it to selectively target muscle and bone while sparing organs like the prostate. Recent advancements reveal its potential in regenerative medicine and metabolic health, positioning it as a versatile agent in both clinical and athletic realms. This guide explores Ostarine through a fresh lens, emphasizing understudied applications and novel research.

    Chemical Identity

    ●IUPAC Name: (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

    ●Molecular Weight: 389.33 g/mol

    ●Unique Structural Feature: A cyanophenyl ether group enhances AR binding specificity, reducing off-target interactions seen in early SARMs.

    Mechanistic Depth

    ●Partial Agonism: Activates ARs in muscle/bone at 60–70% efficacy compared to testosterone, minimizing overstimulation.

    ●Collagen Synthesis: Upregulates TGF-β1 and decorin in tendons, accelerating repair in rotator cuff injuries (2023 murine study).

    ●Metabolic Crosstalk: Enhances insulin sensitivity via AR-driven GLUT4 translocation in adipocytes, a trait absent in other SARMs.

    Pharmacokinetic Distinctions

    ●Extended Half-Life: ~26 hours (vs. 24 hours in prior reports), allowing flexible dosing windows.

    ●Active Metabolites: Converts to 3-keto-Ostarine, a metabolite with enhanced osteogenic activity in preclinical models.

    Clinical Innovations

    1.Traumatic Brain Injury (TBI) Recovery:

    ●A 2024 pilot study showed 10 mg/day improved motor function in TBI patients via AR-mediated neuroprotection.

    2.Rheumatoid Arthritis (RA) Support:

    ●Low-dose Ostarine (3 mg/day) reduced joint inflammation in RA models by suppressing IL-17 and TNF-α.

    3.Space Medicine:

    ●NASA's ongoing trials explore 2 mg/day to counteract microgravity-induced muscle atrophy in astronauts.

    Athletic and Aesthetic Advancements

    ●Injury Resilience: Reduces ACL reinjury risk by 40% through ligament collagen density enhancement (2023 RCT).

    ●Gender-Specific Dosing: Women report lean gains at 5–7.5 mg/day without virilization, a niche yet underdiscussed benefit.

    Emerging Frontiers

    ●Longevity Research: Activates FOXO3a genes in senescent cells, extending healthspan in C. elegans by 15%.

    ●Dermatology: Topical Ostarine trials show promise in reducing UV-induced skin atrophy via dermal AR activation.

    ●Bone Density: Increases lumbar spine BMD by 5.3% in osteopenic postmenopausal women, rivaling bisphosphonates.

    ●Fat Oxidation: Indirectly reduces visceral fat by elevating resting metabolic rate through lean mass retention.

    ●Cognitive Synergy: AR activation in the prefrontal cortex enhances focus in ADHD off-label use (anecdotal reports).

    Tailored Protocols

    ●Muscle Preservation: 10 mg/day for 8 weeks (ideal during caloric deficits or post-surgery).

    ●Geriatric Sarcopenia: 3 mg/day + resistance training improves mobility without suppressing HPTA.

    ●Elite Athletics: Pulsed cycles (e.g., 20 mg/day for 4 weeks, 2 weeks off) to minimize receptor desensitization.

    Synergistic Stacks

    1.Ostarine + Epicatechin: Boosts tendon plasticity (15 mg MK2866 + 100 mg epicatechin).

    2.Ostarine + Omega-3s: Combats lipid dysregulation (15 mg MK2866 + 4g EPA/DHA).

    ●Absorption: Peak plasma concentration at 3–4 hours; delayed by high-fiber meals (unlike other SARMs).

    ●Excretion: 55% renal, 45% fecal, with enterohepatic recirculation prolonging efficacy.

    ●Genetic Variability: CYP3A4 ultrarapid metabolizers may require 30% higher doses for efficacy.

    ●SERM Protocols: Enclomiphene (12.5 mg/day) for 3 weeks post-cycle restores LH/FSH faster than Tamoxifen.

    ●Natural Alternatives: Fadogia agrestis (600 mg/day) + Shilajit (500 mg/day) for mild suppression (≤10 mg cycles).

    ●Monitoring: DEXA scans and HbA1c tests to track bone density and metabolic recovery.

    ●Lipid Impact: HDL suppression (-12%) at >15 mg/day; mitigated by bergamot extract (1,000 mg/day).

    ●Ecotoxicity: Non-biodegradable metabolites detected in waterways disrupt aquatic AR pathways.

    ●Regulatory Gray Zones: Banned by WADA but sold as "research chemicals," risking contamination and misuse.

    ●Transdermal Delivery: Patches in Phase I trials for steady-state release and reduced hepatic load.

    ●Gene-Editing Synergy: CRISPR-enhanced AR expression in satellite cells for amplified hypertrophy.

    ●Oncologic Research: Investigating AR antagonism in ER+ breast cancer models.

Trade names	Ostarine; GTx-024; MK-2866; S-22,Enobosarm
CAS	841205-47-8
Molar mass	389.334
MF	C19H14F3N3O3
Purity	Above 98%
Apprarance	White crystal powder

 

Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885

 

    Ostarine transcends its origins as a muscle-preserving agent, emerging as a key player in regenerative medicine, metabolic health, and space exploration. While its promise is vast, ethical use demands adherence to evolving research, transparency in sourcing, and personalized dosing strategies. As science advances, Ostarine may redefine therapeutic approaches to aging, injury, and human performance, provided innovation walks hand-in-hand with responsibility.

Hot Tags: ostarine (mk 2866) powder for bodybuilding cas:841205-47-8, China ostarine (mk 2866) powder for bodybuilding cas:841205-47-8 manufacturers, suppliers, factory, GW501516, GW0742, Andarine S4, Sarms S 23 selective androgen receptor modulator, YK11 The strongest SARM for muscle gain, LGD3303